Analysts at Research Capital have maintained their ‘Speculative Buy’ rating for Royal Helium Ltd (TSX-V:RHC, OTCQB:RHCCF) on the “positive” news that it has commenced the start-up of its Steveville helium purification facility after completing the commissioning phase.
They have also stuck to their $1.15 price target for the stock.
There could be some market-moving updates for industrial metals at the upcoming large-cap mining reporting season, with Anglo American PLC (LSE:AAL) selected by JPMorgan as its 'top tip'.
The season for the European miners kicks off with operational results for Rio Tinto PLC (LSE:RIO) on 17 October and fellow Anglo-Aussie giant BHP Group Ltd (LSE:BHP, ASX:BHP) and Antofagasta PLC (LSE:ANTO) the day after, with Anglo American and Fresnillo PLC (LSE:FRES) the week after, and Glencore PLC (LSE:GLEN) wrapping things up on the final Monday of the month.
Wagamama-owner The Restaurant Group PLC (LSE:RTN) could be poised to receive another bid after the takeover offer of 65p per share from Apollo Funds, was deemed too low by some analysts and investors.
“We do not believe it reflects the quality of the estate (especially having recently exited the challenged leisure business), the freehold asset backing (c £160 million) and the progress it was making across its strategic objectives on margin accretion (250-350bps) and deleveraging (under 1.5x EBITDA),” analysts at Shore Capital said.
Publicly traded companies offer better value right now than the private sector — that’s the verdict of a majority of private equity investors polled in a study by the investment banking arm of Numis.
The study by Numis Securities, which polled 200 senior private-equity professionals who invest in the UK mid-market, is the latest testament to a gaping disconnect between high private company valuations and comparably cheap publicly listed companies.
Stifel, the American investment bank, has initiated coverage of hVIVO PLC, the contract research organisation (CRO) specialising in human challenge clinical trials (HCTs), with a target share price of 27p.
This represents a 42% premium over the firm's current share price of 19p. The bullish stance from Stifel comes as hVIVO continues to demonstrate robust financial performance and strategic value in the pharmaceutical and biotechnology sectors.
GSK PLC's (LSE:GSK, NYSE:GSK) latest out-of-court Zantac deal is important to the ongoing "overhang" over the investment case, Citigroup said.
The US investment bank reiterated its belief that the FTSE 100 group will ultimately settle the entirety of the Zantac litigation "for $5bn or less" in the first quarter of 2024.
Budget airline easyJet PLC slipped by over 4% on Thursday, despite unveiling ambitious plans to increase its fleet size and score pre-tax profits of £1 billion in the medium term.
Updating on the back of record summer trading, easyJet said full-year headline profit before tax would come in between £440 million and £460 million.
This week saw trading updates from three prominent London-listed recruitment agencies, with Robert Walters PLC (LSE:RWA)’s interims and PageGroup PLC (LSE:PAGE)’s third-quarter results providing an entrée to Hays PLC (LSE:HAS)’s first-quarter result on Thursday.
While all three are under significant macroeconomic pressures, Hays, the largest of the bunch, has emerged as the strongest member of the trio.